In series:OECD Studies on Waterview more titles
Published on November 13, 2019
|OECD Policy Recommendations on addressing pharmaceutical residues in freshwater|
|Defining the challenge of managing pharmaceuticals in water|
|Opportunities to build a policy-relevant knowledge base|
|Emerging policy instruments for the control of pharmaceuticals in water|
|Recommendations for the management of pharmaceuticals in freshwater|
"A combination of promoting hygiene practices to reduce the incidence of infection and disease, encouraging sustainable pharmaceutical design and production, spreading awareness of responsible pharmaceutical use and disposal, and improving environmental monitoring and risk assessment of pharmaceuticals, are critical steps to achieving the dual sustainable development goals of improving health and protecting the environment."
Rodolfo Lacy – OECD Environment Director
GREEN TALKS LIVE WEBINAR
On Thursday 14 November, Hannah Leckie and Bob Diderich of the Environment Directorate presented the key findings of the report, and how policy makers and other stakeholders can take action to reduce the risks. Watch the video recording.
OECD’s Hannah Leckie presents and discusses the key findings and recommendations of the report:
infographic - Major pathways of release of human and veterinary pharmaceuticals into the environment
Number of pharmaceuticals detected in surface water, groundwater or drinking water globally
Source: aus der Beek, T. et al. (2016), “Pharmaceuticals in the environment-Global occurrences and perspectives”, Environmental Toxicology and Chemistry, Vol. 35/4, pp. 823-835, http://dx.doi.org/10.1002/etc.3339.